Maravai Financial Statements From 2010 to 2026

Stocks . USA . 
Stock . Maravai Lifesciences Holdings
MRVI Stock  USD 3.07  0.09  3.02%   
Maravai Lifesciences' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Maravai Lifesciences' valuation are provided below:
Gross Profit
40.5 M
Profit Margin
(0.63)
Market Capitalization
1.1 B
Enterprise Value Revenue
2.877
Revenue
192.4 M
We have found one hundred twenty available fundamental ratios for Maravai Lifesciences, which can be analyzed and compared to other ratios and to its peers in the industry. Traders should compare all of Maravai Lifesciences last-minute fundamentals against the fundamentals between 2010 and 2026 to make sure the company is sustainable this year. The current Market Cap is estimated to decrease to about 1.6 B. Enterprise Value is estimated to decrease to about 1.6 B

Maravai Lifesciences Total Revenue

437.08 Million

Check Maravai Lifesciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Maravai Lifesciences' main balance sheet or income statement drivers, such as Depreciation And Amortization of 37.8 M, Interest Expense of 36.5 M or Selling General Administrative of 113.9 M, as well as many indicators such as Price To Sales Ratio of 3.17, Dividend Yield of 0.0157 or PTB Ratio of 2.52. Maravai financial statements analysis is a perfect complement when working with Maravai Lifesciences Valuation or Volatility modules.
  
Build AI portfolio with Maravai Stock
Check out the analysis of Maravai Lifesciences Correlation against competitors.

Maravai Lifesciences Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets1.4 B1.2 B940.5 M
Slightly volatile
Short and Long Term Debt Total545.1 M433.2 M421.6 M
Slightly volatile
Other Current Liabilities50.3 M31.3 M36.2 M
Slightly volatile
Total Current Liabilities85.6 M65.5 M57.8 M
Slightly volatile
Total Stockholder Equity310.7 M374.1 M224.5 M
Slightly volatile
Other Liabilities405.2 M797.4 M269.3 M
Slightly volatile
Property Plant And Equipment Net139.8 M249.6 M95.3 M
Slightly volatile
Current Deferred Revenue2.8 M3 M6.9 M
Pretty Stable
Accounts Payable8 M13.8 M6 M
Slightly volatile
Cash371.4 M370.8 M193 M
Slightly volatile
Non Current Assets Total930.5 M666 M670.9 M
Slightly volatile
Non Currrent Assets Other10.5 M8.3 M5.5 M
Slightly volatile
Other Assets973.4 M927 M328 M
Slightly volatile
Long Term Debt480 M334.1 M385.5 M
Slightly volatile
Cash And Short Term Investments371.4 M370.8 M193 M
Slightly volatile
Net Receivables69.7 M44.3 M40.3 M
Slightly volatile
Good Will250.7 M183.9 M224.9 M
Very volatile
Common Stock Total Equity2.2 M2.3 M108.6 M
Slightly volatile
Common Stock Shares Outstanding126.6 M158.6 M106 M
Slightly volatile
Liabilities And Stockholders Equity1.4 B1.2 B940.5 M
Slightly volatile
Non Current Liabilities Total828.9 M430.2 M551.7 M
Slightly volatile
Capital Lease Obligations53.4 M92.9 M29.5 M
Slightly volatile
Inventory40.5 M57.6 M27.7 M
Slightly volatile
Other Current Assets15.4 M20.9 M8.7 M
Slightly volatile
Other Stockholder Equity105.9 M209.2 M60.1 M
Slightly volatile
Total Liabilities914.5 M495.7 M609.6 M
Slightly volatile
Net Invested Capital795.9 M714.4 M613.8 M
Slightly volatile
Property Plant And Equipment Gross325.7 M310.2 M113 M
Slightly volatile
Short and Long Term Debt5.2 M6.3 M3.8 M
Slightly volatile
Total Current Assets497 M493.5 M269.6 M
Slightly volatile
Capital Stock2.2 M2.3 M108.6 M
Slightly volatile
Non Current Liabilities Other462.1 K486.4 K47.2 M
Pretty Stable
Net Working Capital411.5 M428 M211.8 M
Slightly volatile
Short Term Debt9.3 M15.8 M6.1 M
Slightly volatile
Intangible Assets211.2 M224.2 M207.3 M
Pretty Stable
Common Stock2.2 M2.3 M108.6 M
Slightly volatile
Property Plant Equipment88.2 M134.1 M70.4 M
Slightly volatile
Deferred Long Term Liabilities2.2 M2 M3 M
Slightly volatile
Noncontrolling Interest In Consolidated Entity183.9 M206.9 M225.8 M
Slightly volatile
Retained Earnings Total Equity147.6 M166.1 M181.3 M
Slightly volatile
Long Term Debt Total419.7 M472.1 M515.3 M
Slightly volatile
Capital Surpluse102.7 M115.5 M126.1 M
Slightly volatile

Maravai Lifesciences Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization37.8 M65.4 M30.8 M
Slightly volatile
Interest Expense36.5 M54.9 M31.9 M
Slightly volatile
Selling General Administrative113.9 M186 M79.7 M
Slightly volatile
Total Revenue437.1 M298.1 M265.1 M
Slightly volatile
Gross Profit118.3 M124.6 M159.6 M
Slightly volatile
Other Operating Expenses597.5 M569 M222.2 M
Slightly volatile
Research Development13.8 M22.1 M9.4 M
Slightly volatile
Cost Of Revenue128.3 M173.5 M94.4 M
Slightly volatile
Total Operating Expenses415.3 M395.5 M124.6 M
Slightly volatile
Reconciled Depreciation37.4 M65.4 M30.6 M
Slightly volatile
Non Operating Income Net Other223.2 K251.1 K274.1 K
Slightly volatile

Maravai Lifesciences Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation59.7 M56.8 M16.2 M
Slightly volatile
Begin Period Cash Flow694.3 M661.2 M218.2 M
Slightly volatile
Depreciation37.8 M65.4 M30.8 M
Slightly volatile
Dividends Paid250.8 M176.5 M130.3 M
Slightly volatile
Capital Expenditures27.2 M34.1 M15.5 M
Slightly volatile
End Period Cash Flow371.4 M370.8 M193 M
Slightly volatile
Cash And Cash Equivalents Changes252.1 M283.7 M309.6 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio3.173.3314.3084
Slightly volatile
Dividend Yield0.01570.01760.0193
Slightly volatile
PTB Ratio2.522.6614.4002
Slightly volatile
Days Sales Outstanding45.4548.8251.1168
Slightly volatile
Book Value Per Share3.043.772.7463
Slightly volatile
Stock Based Compensation To Revenue0.180.170.0557
Slightly volatile
Capex To Depreciation0.540.470.4161
Slightly volatile
PB Ratio2.522.6614.4002
Slightly volatile
EV To Sales6.266.5928.8688
Slightly volatile
Inventory Turnover3.753.463.8282
Slightly volatile
Days Of Inventory On Hand90.3410998.6714
Slightly volatile
Payables Turnover19.5514.5117.2558
Very volatile
Sales General And Administrative To Revenue0.260.30.3265
Slightly volatile
Research And Ddevelopement To Revenue0.07010.06670.0409
Slightly volatile
Capex To Revenue0.07060.10.0601
Slightly volatile
Cash Per Share2.22.11.5009
Slightly volatile
Days Payables Outstanding26.0233.2723.412
Slightly volatile
Intangibles To Total Assets0.460.40.6097
Slightly volatile
Current Ratio4.266.783.5429
Slightly volatile
Receivables Turnover7.237.747.2296
Slightly volatile
Shareholders Equity Per Share1.872.121.964
Slightly volatile
Debt To Equity1.271.332.2787
Pretty Stable
Capex Per Share0.170.190.1257
Slightly volatile
Revenue Per Share2.71.692.299
Slightly volatile
Interest Debt Per Share5.163.544.3865
Pretty Stable
Debt To Assets0.480.430.5329
Slightly volatile
Graham Number7.0611.246.4837
Slightly volatile
Operating Cycle136158150
Slightly volatile
Price Book Value Ratio2.522.6614.4002
Slightly volatile
Days Of Payables Outstanding26.0233.2723.412
Slightly volatile
Company Equity Multiplier6.153.564.6307
Pretty Stable
Long Term Debt To Capitalization0.690.540.6601
Slightly volatile
Total Debt To Capitalization0.730.620.6803
Slightly volatile
Debt Equity Ratio1.271.332.2787
Pretty Stable
Quick Ratio3.855.993.0765
Slightly volatile
Cash Ratio3.15.092.3624
Slightly volatile
Cash Conversion Cycle117132127
Slightly volatile
Days Of Inventory Outstanding90.3410998.6714
Slightly volatile
Days Of Sales Outstanding45.4548.8251.1168
Slightly volatile
Price To Book Ratio2.522.6614.4002
Slightly volatile
Fixed Asset Turnover1.31.373.0358
Very volatile
Debt Ratio0.480.430.5329
Slightly volatile
Price Sales Ratio3.173.3314.3084
Slightly volatile
Asset Turnover0.220.230.2495
Pretty Stable
Gross Profit Margin0.670.480.5601
Slightly volatile
Price Fair Value2.522.6614.4002
Slightly volatile

Maravai Lifesciences Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap1.6 B1.6 B4.4 B
Slightly volatile
Enterprise Value1.6 B1.7 B4.6 B
Slightly volatile

Maravai Fundamental Market Drivers

Forward Price Earnings370.3704
Cash And Short Term Investments322.4 M

Maravai Upcoming Events

28th of February 2024
Upcoming Quarterly Report
View
13th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
28th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Maravai Lifesciences Financial Statements

Investors use fundamental indicators, such as Maravai Lifesciences' revenue or net income, to determine how well the company is positioned to perform in the future. Although Maravai Lifesciences' investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Current Deferred Revenue3 M2.8 M
Total Revenue298.1 M437.1 M
Cost Of Revenue173.5 M128.3 M
Stock Based Compensation To Revenue 0.17  0.18 
Sales General And Administrative To Revenue 0.30  0.26 
Research And Ddevelopement To Revenue 0.07  0.07 
Capex To Revenue 0.10  0.07 
Revenue Per Share 1.69  2.70 
Ebit Per Revenue(1.05)(0.99)

Currently Active Assets on Macroaxis

FSLYFastly Class A
MOBMobilicom Limited American
CMGChipotle Mexican Grill
CSANCosan SA ADR
RKTRocket Companies
When determining whether Maravai Lifesciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Maravai Lifesciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Maravai Lifesciences Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Maravai Lifesciences Holdings Stock:
How To Invest In Maravai
Details
Is Maravai Stock a good investment?
Details
What is Maravai Lifesciences' Net Worth?
Details
Largest Life Sciences Tools & Services Companies
View
Largest Pharmaceuticals, Biotechnology & Life Sciences Companies
View
Check out the analysis of Maravai Lifesciences Correlation against competitors.
You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Is there potential for Life Sciences Tools & Services market expansion? Will Maravai introduce new products? Factors like these will boost the valuation of Maravai Lifesciences. Expected growth trajectory for Maravai significantly influences the price investors are willing to assign. Understanding fair value requires weighing current performance against future potential. All the valuation information about Maravai Lifesciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.33)
Earnings Share
(0.84)
Revenue Per Share
1.341
Quarterly Revenue Growth
(0.40)
Return On Assets
(0.08)
Understanding Maravai Lifesciences requires distinguishing between market price and book value, where the latter reflects Maravai's accounting equity. The concept of intrinsic value - what Maravai Lifesciences' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Market sentiment, economic cycles, and investor behavior can push Maravai Lifesciences' price substantially above or below its fundamental value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Earnings
Projections
Details
Understanding that Maravai Lifesciences' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Maravai Lifesciences represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, Maravai Lifesciences' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY